---
id: FC-320
type: Flashcard
created: 2025-08-08 10:01:43.636844
tags:
- Flashcard
- question
- cardiovascular
topic: cardiovascular
answer: A
related_articles:
- title: Liraglutide Is Probably the Best Second Drug to Prevent Cardiovascular Events
    in Patients With Type 2 Diabetes Mellitus Who Take Metformin.
  path: 2023/2023-04-liraglutide-is-probably-the-best-second-drug-to-prevent-card.md
  similarity: 0.667
  link: '[[2023/2023-04-liraglutide-is-probably-the-best-second-drug-to-prevent-card|Liraglutide
    Is Probably the Best Second Drug to Prevent Cardiovascular Events in Patients
    With Type 2 Diabetes Mellitus Who Take Metformin.]]'
- title: In Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major
    Adverse Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.
  path: 2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists.md
  similarity: 0.667
  link: '[[2025/2025-03-in-older-adults-with-type-2-diabetes-glp-1-receptor-agonists|In
    Older Adults With Type 2 Diabetes, GLP-1 Receptor Agonists Decrease Major Adverse
    Cardiovascular Events; SGLT-2 Inhibitors Prevent Heart Failure Hospitalizations.]]'
- title: SGLT-2 Inhibitors Reduce Heart Failure-Related Hospitalization in Patients
    Without Diabetes.
  path: 2022/2022-10-sglt-2-inhibitors-reduce-heart-failure-related-hospitalizati.md
  similarity: 0.538
  link: '[[2022/2022-10-sglt-2-inhibitors-reduce-heart-failure-related-hospitalizati|SGLT-2
    Inhibitors Reduce Heart Failure-Related Hospitalization in Patients Without Diabetes.]]'
- title: 'Obstructive Sleep Apnea in Adults: Common Questions and Answers.'
  path: 2024/2024-07-obstructive-sleep-apnea-in-adults-common-questions-and-answe.md
  similarity: 0.526
  link: '[[2024/2024-07-obstructive-sleep-apnea-in-adults-common-questions-and-answe|Obstructive
    Sleep Apnea in Adults: Common Questions and Answers.]]'
- title: ACC/AHA Guideline for the Management of Patients With Chronic Coronary Disease.
  path: 2024/2024-03-accaha-guideline-for-the-management-of-patients-with-chronic.md
  similarity: 0.5
  link: '[[2024/2024-03-accaha-guideline-for-the-management-of-patients-with-chronic|ACC/AHA
    Guideline for the Management of Patients With Chronic Coronary Disease.]]'
topics:
- Blood Pressure
- Cardiology
- Emergency Medicine
- Endocrinology
- Heart Failure
- Nephrology
- Pharmacology
- Psychiatry
related_articles_2023_2025:
- title: editorial cardiovascular disparities south asian people
  path: 2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people.md
  similarity: 0.307
  link: '[[2024/07/2024-07-editorial-cardiovascular-disparities-south-asian-people|editorial
    cardiovascular disparities south asian people]]'
last_updated: '2025-08-10T20:24:11.221048'
---

# Flashcard FC-320

## Question

A55-year-oldmalecomestoyourclinicforfollow-upofheartfailurewithanejectionfractionof40. His pastmedicalhistoryisnotableforcoronaryarterydisease. Hiscurrentmedicationsincludethefollowing: Aspirin,81 mgdaily Atorvastatin(Lipitor),80 mgdaily Furosemide(Lasix),40 mgdaily Lisinopril(Zestril),40 mgdaily Metoprololsuccinate(Toprol-XL),100 mgdaily Spironolactone(Aldactone),25 mgdaily Todayheisasymptomatic. Hisvitalsignsincludeatemperatureof37.0 C(98.6 F),ablood pressureof 118/75 mm Hg,andaheart rateof60 beats/min. Aphysicalexaminationisunremarkable. Whichoneof thefollowingadditionalmedicationswould bemostappropriatetoreducehisriskforworseningheart failure?

## Answer

**A**

## Explanation

Dapagliflozinisapprovedbythe FDAforthetreatmentofheartfailurewithreducedejectionfraction regardlessofthepresenceofdiabetesmellitus. Multiplestudiesofthisdrughaveshownareductionin theworseningofheartfailureanddeathfromcardiovascularcauses. Digoxinmay beinitiatedinpatientswhoremainsymptomaticdespiteoptimaltherapywithotheragents, butitdoesnotaffectmorbidityormortality. Isosorbidedinitrate/hydralazineprovidesamortalitybenefitin patientswhoareunabletotoleratean ACEinhibitororangiotensinreceptorblocker.lvabradineisasinus nodemodulatorandmayreducehospitalizationorcardiovasculardeathinpatientswitharestingheart rate270 beats/minwhoaretakinga B-blockeratmaximaldosage. Liraglutidereducescardiovascular eventsinpatientswithdiabetesandlikelyhasaroleinheartfailurewithpreservedejectionfraction, a

## References

- AAFPQuestion Bank-Pythonsimplecapture.
- whoremainsymptomaticdespiteoptimaltherapywithotheragents,
- whoareunabletotoleratean ACEinhibitororangiotensinreceptorblocker.
- whoaretakinga B-blockeratmaximaldosage.

